Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Factors Influencing Drug Absorption: Physicochemical Parameters01:22

Factors Influencing Drug Absorption: Physicochemical Parameters

256
The physicochemical characteristics of drugs play a crucial role in formulating stable and bioavailable drug products. The solubility of a drug, governed by the varying pH along the GI tract and its dissociation constant (pKa), is pivotal in determining its ionization state and absorption rate. Notably, weak acids and bases remain unionized and are absorbed more rapidly.
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
256
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry01:20

Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry

196
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
196

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Multileaflet BASILICA to Prevent Coronary Obstruction in a Small Aortic Annulus.

JACC. Cardiovascular interventions·2026
Same author

2026 ACC/AHA/HRS advanced training statement on clinical cardiac electrophysiology (Revision of the 2015 ACC/AHA/HRS advanced training statement on clinical cardiac electrophysiology): A report of the ACC Competency Management Committee.

Heart rhythm·2026
Same author

Brinzolamide microsponge-loaded in situ gel for sustained ocular delivery: design, characterization and in vivo evaluation.

Naunyn-Schmiedeberg's archives of pharmacology·2026
Same author

Disease Course of Axial Spondyloarthritis in Pregnancy.

European journal of rheumatology·2026
Same author

2025 ACC/AHA/ASE/ASNC/SCCT/SCMR advanced training statement on advanced cardiovascular imaging: A Report of the ACC Competency Management Committee.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology·2025
Same author

2025 ACC/AHA/ASE/ASNC/SCCT/SCMR Advanced Training Statement on Advanced Cardiovascular Imaging: A Report of the ACC Competency Management Committee.

Journal of cardiovascular computed tomography·2025

相关实验视频

Updated: Jun 23, 2025

Preparation and Characterization of SDF-1α-Chitosan-Dextran Sulfate Nanoparticles
12:00

Preparation and Characterization of SDF-1α-Chitosan-Dextran Sulfate Nanoparticles

Published on: January 22, 2015

12.4K

设计,优化和表征阿托瓦斯塔丁加载的基托基聚电解质复合物基于纳米颗粒的透皮贴片.

Pravin Patil1, Ankit Vankani1, Krutika Sawant1

  • 1Faculty of Pharmacy, The Maharaja Sayajirao University of Baroda, Vadodara 390001, Gujarat, India.

International journal of biological macromolecules
|June 19, 2024
PubMed
概括

这项研究开发了阿托瓦斯塔丁 (ATO) 装载的基托基聚电解质复合纳米颗粒 (PECN) 透皮贴片. 与口服药片相比,该新型贴片显著提高了ATO的皮肤透性和生物可用性.

关键词:
一个阿托尔瓦斯塔丁.生物可用性 生物可用性优化优化 优化优化复杂的多电解质复合物通过皮肤通过皮肤.

更多相关视频

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
08:18

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs

Published on: July 27, 2022

1.1K
Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

8.9K

相关实验视频

Last Updated: Jun 23, 2025

Preparation and Characterization of SDF-1α-Chitosan-Dextran Sulfate Nanoparticles
12:00

Preparation and Characterization of SDF-1α-Chitosan-Dextran Sulfate Nanoparticles

Published on: January 22, 2015

12.4K
Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
08:18

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs

Published on: July 27, 2022

1.1K
Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

8.9K

科学领域:

  • 制药科学 制药科学
  • 纳米技术纳米技术
  • 药物输送系统 药物输送系统

背景情况:

  • 阿托瓦斯塔丁 (ATO) 的生物可用性较差,需要先进的输送系统.
  • 基索基聚电解质复合纳米颗粒 (PECN) 提供了改善药物输送的潜力.
  • 通过皮肤贴片提供一种非侵入性的药物给药途径.

研究的目的:

  • 为了开发和评估阿托瓦斯塔丁 (ATO) 装载的基托基聚电解质复合纳米颗粒 (PECN) 纳入透皮贴片.
  • 通过一种新的通过皮肤递送系统,提高ATO的皮肤透性和生物可用性.

主要方法:

  • 用ATO装载的PECN使用离子凝方法制备,并使用Box-Behnken设计进行优化.
  • 进行了物理化学特征,体外,体外,细胞系和稳定性研究.
  • 优化的ATO-PECN被纳入皮肤贴片中,随后进行全面评估.

主要成果:

  • 优化的ATO-PECN的粒子大小为219.2 ± 5.98nm,捕获率为82.68 ± 2.63%和+25.41 ± 3.29 mV的泽塔电位.
  • 与ATO悬浮剂相比,ATO-PECN表现出持续的药物释放,增强的皮肤透性和增加的细胞透性.
  • 通过皮肤贴片显示出优异的ex vivo皮肤透性和显著改善的体内药理动力学参数,证实了增强的生物可用性.

结论:

  • 开发的阿托瓦斯塔丁载的PECN皮肤贴是一种有前途的药物输送系统.
  • 这种新的系统有效地提高了阿托瓦斯塔丁等生物可用性较差的药物的生物可用性.
  • 这项研究突出了基托桑基PECN在先进的皮肤过体药物递送应用中的潜力.